Skip to main content
. 2023 Mar 21;59(3):627. doi: 10.3390/medicina59030627

Figure 3.

Figure 3

Figure 3

Figure 3

Genetic subtype study of the patient. (a,b) the immunophenotype characterization with the use of flow cytometry demonstrated moderate cytoplasmic CD79a, CD19, and CD34 expression. (ce) in B-cell precursor acute lymphoblastic leukemia diagnostic panel, the specimen showed brightness of CD58 and CD10 with moderate expression of TdT. (f) reverse transcription polymerase chain reaction revealed significant expression of the BCR-ABL1 gene (p190 form).